RecruitingNCT00246857

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death


Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

5,000 participants

Start Date

Feb 12, 2007

Study Type

OBSERVATIONAL

Conditions

Summary

This study will determine the biochemical and genetic causes of inherited immune diseases affecting lymphocyte homeostasis. Lymphocytes are a type of white blood cell that fights infections. Normally, the body keeps a precise balance in which lymphocyte growth is matched by lymphocyte death. People with constantly enlarged lymph nodes or spleen, along with autoimmune disease, immunodeficiency, lymphoma, or other immune problems affecting lymphocytes may have an abnormality of the immune system in the cell growth and cell death processes that regulate lymphocyte homeostasis. Patients who have, or are suspected of having, an inherited lymphocyte homeostasis or programmed cell death susceptibility syndrome may be eligible for this study. Relatives of patients are also included. Participants' (patients and relatives) medical records are reviewed and blood samples are drawn for studies to identify genes involved in immune disorders. Tissues that have been removed from patients for medical reasons, such as biopsied tissues, may be examined for tissue and DNA studies. Relatives are studied to determine if some of them may have a very mild form of lymphocyte homeostasis disorder. Patients who have an immune problem that the researchers wish to study further will be invited to donate additional blood samples at irregular intervals (at least once a year) and to provide an update of their medical records at the same time. ...


Eligibility

Min Age: 1 MonthMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with primary immune deficiency. The study is currently recruiting participants at 7 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(8)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

University of Michigan

Ann Arbor, Michigan, United States

Ankara Medical University

Ankara, Turkey (Türkiye)

Gazi University

Ankara, Turkey (Türkiye)

Hacettepe University

Ankara, Turkey (Türkiye)

Marmara University

Istanbul, Turkey (Türkiye)

Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital

Istanbul, Turkey (Türkiye)

Necemttin Erbakan University

Konya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00246857


Related Trials